These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7684845)

  • 1. Underfeeding-induced suppression of mammary tumors: counteraction by estrogen and haloperidol.
    ThyagaRajan S; Meites J; Quadri SK
    Proc Soc Exp Biol Med; 1993 Jun; 203(2):236-42. PubMed ID: 7684845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Counteraction of underfeeding-induced inhibition of mammary tumor growth in rats by prolactin and estrogen administration.
    Leung FC; Alysworth CF; Meites J
    Proc Soc Exp Biol Med; 1983 May; 173(1):159-63. PubMed ID: 6856617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of hormones to inhibition of mammary tumor development by underfeeding during the "critical period" after carcinogen administration.
    Sylvester PW; Aylsworth CF; Meites J
    Cancer Res; 1981 Apr; 41(4):1384-8. PubMed ID: 6783295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
    Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
    Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors.
    ThyagaRajan S; Quadri SK
    Endocrine; 1999 Jun; 10(3):225-32. PubMed ID: 10484286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of somatostatin analogs on prolactin secretion in rats pretreated with estrogen or haloperidol.
    Karashima T; Schally AV
    Proc Soc Exp Biol Med; 1987 May; 185(1):69-75. PubMed ID: 2883661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of dopaminergic modulators in a tier I screening battery for identifying endocrine-active compounds (EACs).
    O'Connor JC; Davis LG; Frame SR; Cook JC
    Reprod Toxicol; 2000; 14(3):193-205. PubMed ID: 10838120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
    Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
    Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of prolactin in chloro-S-triazine rat mammary tumorigenesis.
    O'Connor JC; Plowchalk DR; Van Pelt CS; Davis LG; Cook JC
    Drug Chem Toxicol; 2000 Nov; 23(4):575-601. PubMed ID: 11071396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive experience reduces haloperidol-induced prolactin secretion in female rats.
    Bridges RS; Henriquez BM; Sturgis JD; Mann PE
    Neuroendocrinology; 1997 Nov; 66(5):321-6. PubMed ID: 9387851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
    Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S
    Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for the stimulatory effects of opioidergic and serotonergic input signals on prolactin in pregnant rats.
    Sagrillo CA; Voogt JL
    Life Sci; 1992; 50(20):1479-89. PubMed ID: 1579043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic hyperprolactinemia on tuberoinfundibular dopaminergic neurons.
    MohanKumar PS; MohanKumar SM; Arbogast L; Quadri SK; Voogt JL
    Proc Soc Exp Biol Med; 1998 Apr; 217(4):461-5. PubMed ID: 9521094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of the neuroendocrine system to the development and growth of experimental mammary tumors.
    Meites J
    J Neural Transm; 1980; 48(1):25-42. PubMed ID: 6106045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic dopamine is required for salsolinol-induced prolactin secretion in goats.
    Hashizume T; Watanabe R; Inaba Y; Sawai K; Fülöp F; Nagy GM
    Anim Sci J; 2017 Oct; 88(10):1588-1594. PubMed ID: 28556305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting-refeeding stimulates the development of mammary tumors induced by 7,12-dimethylbenz[a]anthracene.
    Sesca E; Premoselli F; Binasco V; Bollito E; Tessitore L
    Nutr Cancer; 1998; 30(1):25-30. PubMed ID: 9507509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene-(DMBA)-induced mammary tumorigenesis.
    Blask DE; Hill SM; Orstead KM; Massa JS
    J Neural Transm; 1986; 67(1-2):125-38. PubMed ID: 3097252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic stimulation of pituitary but not hypothalamic estrogen receptors in ovariectomized rats.
    Carrillo AJ; Steger RW; Chamness GC
    Endocrinology; 1983 May; 112(5):1839-46. PubMed ID: 6131816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.